1. [18F]fluorothymidine PET Informs the Synergistic Efficacy of Capecitabine and Trifluridine/Tipiracil in Colon Cancer
   Seog-Young Kim et al, 2017, Cancer Research CrossRef
2. Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?
   Federica Tomao et al, 2021, Expert Opinion on Drug Safety CrossRef
3. How can we improve adjuvant chemotherapy for colon cancer?
   Narikazu Boku, 2014, The Lancet Oncology CrossRef
4. Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells
   Lucia Kucerova et al, 2017, Cancer Letters CrossRef
5. Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells
   Lenka Toro et al, 2016, Stem Cells and Development CrossRef
6. Minimally toxic approach for treatment of cutaneous breast cancer metastases: capecitabine-enhanced photodynamic therapy
   David H. Kessel et al, 2017, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI CrossRef
7. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers
   Mostafa Vaghari-Tabari et al, 2024, Biomedicine & Pharmacotherapy CrossRef
8. Thymidine phosphorylase in cancer aggressiveness and chemoresistance
   Tatsuhiko Furukawa et al, 2018, Pharmacological Research CrossRef
9. Clinical Impact of Metronomic Oral Combination Chemotherapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer
   Miwa FUJIHARA et al, 2017, Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) CrossRef
10. Genome‐wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer
    Katie Watts et al, 2021, International Journal of Cancer CrossRef
11. The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine
    Nobuya Kobashi et al, 2016, Journal of Nuclear Medicine CrossRef
12. Non-toxic approach for treatment of breast cancer and its cutaneous metastasis: Capecitabine (Xeloda) enhanced photodynamic therapy in a murine tumor model
    Sanjay Anand et al, 2018, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVII CrossRef
13. Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
    Nikolaos Tsesmetzis et al, 2018, Cancers CrossRef
14. PRIMUM NON NOCERE: now and again an echo of DPD with capecitabine
    Joseph Ciccolini et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef
15. Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model
    SUGURU HARADA et al, 2015, Molecular and Clinical Oncology CrossRef
16. Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
    Satoru Iwasa et al, 2023, Cancer Communications CrossRef